These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7669254)

  • 41. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
    Sample J; Brooks L; Sample C; Young L; Rowe M; Gregory C; Rickinson A; Kieff E
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6343-7. PubMed ID: 1648738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.
    Davenport MG; Pagano JS
    J Virol; 1999 Apr; 73(4):3154-61. PubMed ID: 10074167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
    Robertson ES; Grossman S; Johannsen E; Miller C; Lin J; Tomkinson B; Kieff E
    J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site.
    Ghosh D; Kieff E
    J Virol; 1990 Apr; 64(4):1855-8. PubMed ID: 2157069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ; Crawford DH; Thomas JA
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
    Schaefer BC; Paulson E; Strominger JL; Speck SH
    Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.
    Tomkinson B; Kieff E
    J Virol; 1992 Feb; 66(2):780-9. PubMed ID: 1309912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas.
    Minarovits J; Hu LF; Imai S; Harabuchi Y; Kataura A; Minarovits-Kormuta S; Osato T; Klein G
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():77-84. PubMed ID: 8113742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y; Luo B; Zhao P; Huang BH
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Host factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus.
    Bulfone-Paus S; Dempsey LA; Maizels N
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8293-7. PubMed ID: 7667284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.
    Kerr BM; Lear AL; Rowe M; Croom-Carter D; Young LS; Rookes SM; Gallimore PH; Rickinson AB
    Virology; 1992 Mar; 187(1):189-201. PubMed ID: 1310556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA.
    Ambinder RF; Shah WA; Rawlins DR; Hayward GS; Hayward SD
    J Virol; 1990 May; 64(5):2369-79. PubMed ID: 2157891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency.
    Ruf IK; Sample J
    J Virol; 1999 Oct; 73(10):7943-51. PubMed ID: 10482541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.
    Yoshioka M; Crum MM; Sample JT
    J Virol; 2008 Feb; 82(4):1679-87. PubMed ID: 18077719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.
    Jin XW; Speck SH
    J Virol; 1992 May; 66(5):2846-52. PubMed ID: 1313905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of an internal promoter of the latent membrane protein 1 gene of Epstein-Barr virus.
    Chen ML; Hsu NC; Liu ST; Chang YS
    DNA Cell Biol; 1995 Mar; 14(3):205-11. PubMed ID: 7880441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
    Tsang SF; Wang F; Izumi KM; Kieff E
    J Virol; 1991 Dec; 65(12):6765-71. PubMed ID: 1658373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1.
    Ambinder RF; Mullen MA; Chang YN; Hayward GS; Hayward SD
    J Virol; 1991 Mar; 65(3):1466-78. PubMed ID: 1847464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication.
    Harrison S; Fisenne K; Hearing J
    J Virol; 1994 Mar; 68(3):1913-25. PubMed ID: 8107251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.